Jounce Therapeutics Appoints Perry Karsen to Its Board of Directors
CAMBRIDGE, Mass., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient enrichment, today announced the appointment of Perry A. Karsen to the …